Erectile dysfunction or ED is the consistent inability to
sustain an erection sufficient for sexual intercourse. It can be a total
inability to achieve an erection, an inconsistent ability to do so or a
tendency to sustain only brief erections. Roughly 50% of men between the ages
of 40 and 70 have erectile dysfunction. The causes of erectile dysfunction for
the most part are physical. So what is an erection? An erection is an
involuntary reaction in response to sexual stimulation and excitement. There
are nerves, veins and arteries in the penis and it's the relationship between
these structures that allow the erection to occur. When the chemicals are
produced in the body due to sexual arousal they influence the muscles and blood
flow in the penis. When it's not working properly there are ways that we can
deal with this. Treatment options can include oral medications such as Viagra, Levitra,
and Cialis or vacuum erection devices, injection therapy, urethral
suppositories or penile implants. The oral medications can alter the chemical
reactions normally produced in the body. Injection therapy is similar but
allows for more concentrated higher dosing than the oral medications. When
other treatment options don't work or there are other factors such as a radical
prostatectomy, diabetes, trauma to the penis, severe venous leak or Peyronie’s
disease then we have the option of a penile implant. A penile implant involves
cylinders that fit into the erectile body, a reservoir that goes behind the
abdominal wall and a pump that goes in the scrotum. The penile prosthesis is
totally implanted. When an erection is desired the pump is manipulated to
transfer fluid from the reservoir into the cylinders creating an erection. At
the conclusion that pump is again manipulated allowing the fluid to transfer
from the cylinders back to the reservoir. So there are options you just have to
match the appropriate treatment to the patient.
At Riverside Urology we recognize that disease of any kind can put a patient's life in turmoil. Our focus upon patient quality of life leads us to seek least-invasive solutions leading to best outcomes with minimal life disruption. Our patients benefit from access to the best care, the deepest knowledge and the use of our Ambulatory Surgery Center as an alternative to hospital stays. We help you get your life back to normal as quickly as possible.
Thursday, April 24, 2014
Tuesday, April 22, 2014
AUA 2014
The 2014 Annual Meeting of the American Urological Association will be held in Orlando, Florida from May 16-21, 2014. http://www.aua2014.org
Friday, April 18, 2014
A few stats about prostate cancer.
More than 230,000 men will be diagnosed with prostate cancer in 2014. Prostate cancer costs society more than $2.2 billion annually in Medicare costs not including drug costs. About 10,000 men are told they have advanced prostate cancer each year. The good news is that 2.5 million men in the United States are prostate cancer survivors.
Wednesday, April 16, 2014
High Intensity Focused Ultrasound or HIFU is the newest treatment for prostate cancer.
The newest ablative therapy is High Intensity Focused
Ultrasound (HIFU). HIFU is a sophisticated, technical system that precisely
directs energy only to the prostate cells. This technology can be compared to a
magnifying glass that focuses the sun’s rays to ignite a piece of paper. A hand placed between the magnifying glass
and the paper does not get hot.
So too with HIFU, the normal tissues are cool, while the
“significant” cancer is treated with the heat of focused ultrasound. By
combining the image from a 3T MRI and HIFU system, we are able to spare the
nerves and vessels that maintain erection, continence, ejaculatory function and
a large portion of the prostate gland.
This produces a very rapid recovery in days, rather than weeks or
months.
Monday, April 14, 2014
Focal Therapy, it's like taking care of the bad spot in the apple instead of throwing the whole thing away.
When we can distinguish “significant” prostate cancer from
non-aggressive prostate cancer, ablative treatment options can be considered.
When minimally invasive ablative therapy is used, it can treat the entire
prostate gland or just the area with the known disease. Treating only the
“significant” prostate cancer is known as focal therapy. Focal therapy
eliminates the aggressive cells without destroying the rest of the prostate.
This minimizes the potential for urinary incontinence or sexual dysfunction.
Focal prostate treatment is similar to the advancing
technology for breast cancer. Today, lumpectomy has largely replaced the
radical mastectomy. Another way of
thinking about focal treatment is to consider an apple with a bad spot. Rather
than tossing the whole apple, only the bad spot is removed.
Wednesday, April 9, 2014
What does it mean when we put a patient on Active Surveillance?
In some cases, when a non-aggressive prostate cancer is
diagnosed active surveillance is the appropriate treatment option. It is
considered a treatment since it requires careful monitoring and follow-up.
PSAs, digital rectal exams, imaging studies and prostate biopsies are routinely
scheduled. If progression of the disease is identified other treatment options
should be considered.
This type of surveillance is recommended only in cases of
prostate confined, low grade, low volume cancers. Only men who are committed to this type of
treatment plan should be considered for active surveillance. Some men who
initially decided on active surveillance change course and opt for another
treatment because of the rigors of follow up or because they are uncomfortable
with the knowledge that they have a
cancer and want to do something more.
Monday, April 7, 2014
What is "significant" prostate cancer?
What is “significant” prostate cancer? Genetic research has
concluded that cancers, found in the prostate, are not all life-threatening.
The life-threatening cancers are referred to as “significant” cancer and do
require treatment.
The ability to differentiate the aggressive, significant
cancer from non-aggressive cancer opens up more treatment options including
focal ablative therapy. Ablative therapy can treat the entire prostate or just the
area(s) with the aggressive cancer cells. If treatment is directed only to the aggressive
cells it is referred to as focal therapy. Focal therapy eliminates the
aggressive cells without destroying the rest of the prostate. This minimizes
the potential for sexual dysfunction and urinary incontinence.
Focal prostate
treatment is similar to the advancing technology for breast cancer. Today
lumpectomy has largely replaced the radical mastectomy. Another way of thinking
about focal treatment is to consider an apple with a bad spot. Rather than
tossing the whole apple, only the bad spot is removed.
Friday, April 4, 2014
3T MRI, what's that?
Magnetic resonance imaging, MRI, is an excellent study that does not use radiation. It produces images of organs. A newer MRI known as the 3-Tesla, or 3T, uses a more powerful magnet and can be used to provide us with a better image of the prostate. The 3T MRI actually looks inside the prostate and allows us to visualize down to the cellular level. This allows us to see the development of cancer at its very early stage. We then have an opportunity to do targeted biopsies so that we can determine if it is a cancer that needs to be treated. If the 3T MRI is negative, a prostate biopsy may not be necessary.
Subscribe to:
Posts (Atom)